Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Research from the STEP programme (semaglutide), SCALE studies (liraglutide), and SURMOUNT trials (tirzepatide) consistently demonstrates significant reductions in waist circumference, which correlates with abdominal fat loss
Retrieved from Pietilinen, K
The starting dosage for this use is usually 2.5 mg injected once per week for 4 weeks
Browse all Peptides and GLP-1 education Retatrutide cost is one of the most-searched questions in the GLP-1 and incretin-pathway landscape as of May 2026
Visual changes often precede or exceed what the scale shows
The primary outcome occurred in 9.2% of patients in the dapagliflozin group compared to 14.5% in the placebo group, results that were statistically significant
US$ 23.56
US$ 29.16
US$ 28.16
